FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells

Oncogene

Volumn 22, Issue 58, 2003, Pages 9231-9242

  Imai, Tsuyoshi ^a   Adachi, Souichi ^a   Nishijo, Koichi ^a   Ohgushi, Masatoshi ^a   Okada, Masayuki ^a   Yasumi, Takahiro ^a   Watanabe, Ken Ichiro ^a   Nishikomori, Ryuta ^a   Nakayama, Tomitaka ^a   Yonehara, Shin ^a   Toguchida, Junya ^b   Nakahata, Tatsutoshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Fas; Fas ligand; Histone deacetylase inhibitor; Osteosarcoma

Indexed keywords

CASPASE 3; CASPASE 8; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FLICE INHIBITORY PROTEIN; FR 901228; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MODEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; SENSITIZATION; SIGNAL TRANSDUCTION; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HISTONES; HUMANS; IN SITU NICK-END LABELING; INHIBITORY CONCENTRATION 50; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; OSTEOSARCOMA; PEPTIDES, CYCLIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

ANIMALIA; MUS MUSCULUS;

EID: 9144228629     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207184     Document Type: Article

References (76)

1. Adachi S, Cross AR, Babior BM and Gottlieb RA. (1997). J. Biol Chem., 272, 21878-21882.
2. Archer SY, Meng S, Shei A and Hodin RA. (1998). Proc. Natl. Acad. Sci. USA, 95, 6791-6796.
3. Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME, Shen T, Murphy T, Wickham J, Kanakry C, Lucas DM, Reed JC, Grever MR and Byrd JC. (2003). Blood, 102, 652-658.
4. Bernhard D, Skvortsov S, Tinhofer I, Hubl H, Greil R, Csordas A and Kofler R. (2001). Cell Death Differ., 8, 1014-1021.
5. Beron G, Euler A and Winkler K. (1985). Eur. Paediatr. Haematol. Oncol., 2, 77-85.
6. Bonnette B, Favre N, Reveneau S, Micheau O, Droin N, Garrido C, Fontana A, Chauffert B, Solary E and Martin F. (1998). Cell Death Differ., 5, 480-487.
7. Bradford MM. (1976). Anal. Biochem., 72, 248-254.
8. Bramwell VH. (2000). Curr. Opin. Oncol., 12, 330-336.
9. Bramwell VH, Burgers M, Sneath R, Souhami R, van Oosterom AT, Voute PA, Rouesse J, Spooner D, Craft AW and Somers R. (1992). J. Clin. Oncol., 10, 1579-1591.
10. Cuisset L, Tichonicky L and Delpech M. (1998). Biochem. Biophys. Res. Commun., 246, 760-764.
11. Debatin KM. (1999). Drug Resist. Updat., 2, 85-90.
12. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S and Goodnight J. (1987). J. Clin. Oncol., 5, 21-26.
13. Fellenberg J, Mau H, Scheuerpflug C, Ewerbeck V and Debatin KM. (1997). Int. J. Cancer, 72, 536-542.
14. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R and Pavletich NP. (1999). Nature, 401, 188-193.
15. Fulda S, Los M, Friesen C and Debatin KM. (1998a). Int. J. Cancer, 76, 105-114.
16. Fulda S, Susin SA, Kroemer G and Debatin KM. (1998b). Cancer Res., 58, 4453-4460.
17. Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H and Whiteside TL. (1999). Cancer Res., 59, 5356-5364.
18. Glick RD, Swendeman SL, Coffey DC, Rifkind RA, Marks PA, Richon VM and La Quaglia MP. (1999). Cancer Res., 59, 4392-4399.
19. Gore SD and Carducci MA. (2000). Expert Opin. Investig. Drugs, 9, 2923-2934.
20. Grunstein M. (1997). Nature, 389, 349-352.
21. Hamada T, Komiya S, Yano H, Zenmyo M, Hiraoka K, Inoue A and Morimatsu M. (1999). Int. J. Oncol., 15, 1125-1131.
22. Haruyama H, Ito S, Miyadai K, Takahashi T, Kawaida R, Takayama T, Hanzawa H, Hata T, Yamaguchi J, Yoshida-Kato H, Ichikawa K, Ohsumi J, Yonehara S and Serizawa N. (2002). Biol. Pharm. Bull., 25, 1537-1545.
23. Herr I and Debatin KM. (2001). Blood, 98, 2603-2614.
24. Hickman ES, Moroni MC and Helin K. (2002). Curr. Opin. Genet. Dev., 12, 60-66.
25. Himelstein BP. (1998). Curr. Opin. Oncol., 10, 326-333.
26. Hock JM, Krishnan V, Onyia JE, Bidwell JP, Milas J and Stanislaus D. (2001). J. Bone Miner. Res., 16, 975-984.
27. Imai Y, Kimura T, Murakami A, Yajima N, Sakamaki K and Yonehara S. (1999). Nature, 398, 777-785.
28. Ishii S, Yamawaki S, Sasaki T, Usui M, Ubayama Y, Minami A, Yagi T, Isu K and Kobayashi M. (1982). Int. Orthop., 6, 215-223.
29. Jaboin J, Wild J, Hamidi H, Khanna C, Kim CJ, Robey R, Bates SE and Thiele CJ. (2002). Cancer Res., 62, 6108-6115.
30. Kaufmann SH and Earnshaw WC. (2000). Exp. Cell Res., 256, 42-49.
31. Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y and Tasaka K. (2000). Int. J. Cancer, 88, 986-991.
32. Klisovic DD, Katz SE, Effron D, Klisovic MI, Wickham J, Parthun MR, Guimond M and Marcucci G. (2003). Invest. Ophthalmol. Vis. Sci., 44, 2390-2398.
33. Kosugi H, Ito M, Yamamoto Y, Towatari M, Ueda R, Saito H and Naoe T. (2001). Jpn. J. Cancer Res., 92, 529-536.
34. Kwon SH, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S, Lee HY, Lee YW, Lee HW and Han JW. (2002). J. Biol. Chem., 277, 2073-2080.
35. Lafleur EA, Jia SF, Worth LL, Zhou Z, Owen-Schaub LB and Kleinerman ES. (2001). Cancer Res., 61, 4066-4071.
36. Link MP, Goorin AM, Horowitz M, Meyer WH, Belasco J, Baker A, Ayala A and Shuster J. (1991). Clin. Orthop., 270, 8-14.
37. Lynch MP, Capparelli C, Stein JL, Stein GS and Lian JB. (1998). J. Cell. Biochem., 68, 31-49.
38. Marina MM, Pratt CB, Rao BN, Shema SJ and Meyer WH. (1992). Cancer, 70, 2722-2727.
39. Marks PA, Richon VM, Breslow R and Rifkind RA. (2001a). Curr. Opin. Oncol., 13, 477-483.
40. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME. (1997). EMBO J., 16, 2794-2804.
41. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V and Rosen G. (1992). J. Clin. Oncol., 10, 5-15.
42. Mizutani Y, Okada Y, Yoshida O, Fukumoto M and Bonavida B. (1997). Cancer, 79, 1180-1189.
43. Murakami H, Nakayama T, Nishijo K, Hosaka T, Nakamata T, Aoyama T, Okamoto T, Tsuboyama T, Nakamura T and Toguchida J. (2002). Cancer Lett., 182, 203-211.
44. Nagata S. (1997). Cell, 88, 355-365.
45. Nagata S and Golstein P. (1995). Science, 267, 1156-1449.
46. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H and Sakai T. (1997). J. Biol. Chem., 272, 22199-22206.
47. Nakajima H, Kim YB, Terano H, Yoshida M and Horinouchi S. (1998). Exp. Cell Res., 241, 126-133.
48. Nicholson DW. (2000). Nature, 407, 810-816.
49. O'Connell J, O'Sullivan GC, Collins JK and Shanahan F. (1996). J. Exp. Med., 184, 1075-1082.
50. OhYama T, Tsukumo S, Yajima N, Sakamaki K and Yonehara S. (2000). Microbiol. Immunol., 44, 289-297.
51. Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, Schwarz R, von Hochstetter AR, Salzer-Kuntschik M, Berdel WE, Jurgens H, Exner GU, Reichardt P, Mayer-Steinacker R, Ewerbeck V, Kotz R, Winkelmann W and Bielack SS. (2003). J. Clin. Oncol., 21, 334-341.
52. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA and Klein PS. (2001). J. Biol. Chem., 276, 36734-36741.
53. Piekarz RL, Robey R, Sandor V, Bakke S, Wilson WH, Dahmoush L, Kingma DM, Turner ML, Altemus R and Bates SE. (2001). Blood, 98, 2865-2868.
54. Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M and LoRusso PM. (2001). Invest. New Drugs, 19, 1-11.
55. Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA and Marks PA. (1998). Proc. Natl. Acad. Sci. USA, 95, 3003-3007.
56. Richon VM and O'Brien JP. (2002). Clin. Cancer Res., 8, 662-664.
57. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C and Huvos AG. (1979). Cancer, 43, 2163-2177.
58. Sandor V, Bakke S, Robey RW, Kang MH, Blagosklonny MV, Bender J, Brooks R, Piekarz RL, Tucker E, Figg WD, Chan KK, Goldspiel B, Fojo AT, Balcerzak SP and Bates SE. (2002). Clin. Cancer Res., 8, 718-728.
59. Sandor V, Senderowicz A, Merlins S, Sackett D, Sausville E, Blagosklonny MV and Bates SE. (2000). Br. J. Cancer, 83, 817-825.
60. Sasakawa Y, Naoe Y, Inoue T, Sasakawa T, Matsuo M, Manda T and Mutoh S. (2002). Biochem. Pharmacol., 64, 1079-1090.
61. Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N and Tasaka K. (2000). Cancer Chemother. Pharmacol., 45, 199-206.
62. Shen J, Hovhannisyan H, Lian JB, Montecino MA, Stein GS, Stein JL and Wijnen AJV. (2003). Mol. Endocrinol., 17, 743-756.
63. Struhl K. (1998). Genes Dev., 12, 599-606.
64. Suda T, Takahashi T, Golstein P and Nagata S. (1993). Cell, 75, 1169-1178.
65. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS and Little JB. (1992). Cancer Res., 52, 6194-6199.
66. Trauth BC, Klas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM and Krammer PH. (1989). Science, 245, 301-305.
67. Ueda H, Manda T, Matsumoto S, Mukumoto S, Nishigaki F, Kawamura I and Shimomura K. (1994a). J. Antibiot. (Tokyo), 47, 315-323.
68. Ueda H, Nakajima H, Hori Y, Fujita T, Nishimura M, Goto T and Okuhara M. (1994b). J. Antibiot. (Tokyo), 47, 301-310.
69. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y and Yamamuro T. (1994). Cancer Res., 54, 3042-3048.
70. Wang LH, Okaichi K, Ihara M and Okumura Y. (1998). Anticancer Res., 18, 321-325.
71. Wang R, Brunner T, Zhang L and Shi Y. (1998). Oncogene, 17, 1503-1508.
72. Weiser TS, Guo ZS, Ohnmacht GA, Parkhurst ML, Tong-On P, Marincola FM, Fischette MR, Yu X, Chen GA, Hong JA, Stewart JH, Nguyen DM, Rosenberg SA and Schrump DS. (2001). J. Immunother., 24, 151-161.
73. Wu XX, Mizutani Y, Kakehi Y, Yoshida O and Ogawa O. (2000). Cancer Res., 60, 2912-2918.
74. Yonehara S. (2002). Cytokine Growth Factor Rev., 13, 393-402.
75. Yonehara S, Ishii A and Yonehara M. (1989). J. Exp. Med., 169, 1747-1756.
76. Yoshida M, Kijima M, Akita M and Beppu T. (1990). J. Biol. Chem., 265, 17174-17179.